Global disparities in COVID-19 vaccine booster dose (VBD) acceptance and hesitancy: An updated narrative review
Vaccine X,
Год журнала:
2024,
Номер
18, С. 100480 - 100480
Опубликована: Март 23, 2024
The
global
deployment
of
COVID-19
vaccine
booster
dose
(VBD)
has
been
recognized
as
a
promising
therapeutic
alliance
to
provide
repeated
immunity
against
the
arrival
new
variants.
Despite
scientific
evidence
supports
effectiveness
periodic
doses,
reluctance
continues
thrive.
This
narrative
review
aimed
examine
doses
acceptance
and
summarize
an
up-to-date
assessment
potential
antecedents
associated
with
VBD
acceptance.
A
comprehensive
search
was
performed
in
several
reputable
databases
such
Medline
(via
PubMed),
Scopus,
Google
scholar,
Web
Science
from
June
10th,
2023,
August
1st,
2023.
All
relevant
descriptive
observational
studies
on
hesitancy
were
included
this
review.
total
fifty-eight
(58)
included,
Asia
representing
highest
count
thirty-one
(53
%)
studies,
Europe
eleven
(19
%),
United
States
nine
(16
other
regions
(Africa
multi-ethnic)
seven
(12
%).
Worldwide,
pooled
rate
77.09
%
(95
CI:
76.28–78.18),
willingness
(n)
=
164189,
sample
(N)
212,990.
lowest
reported
American
regions,
respectively,
85.38
85.02–85.73,
32,047,
(N
37,533)
vs.
66.92
66.56–67.4),
29335,
43,832.
However,
multi-ethnic
areas
moderately
high
79.13
78.77–79.23,
93,994,
11,8779)
72.16
71.13–72.93,
9276,
12,853),
respectively.
most
common
key
across
countries
"equal
safety",
"efficacy",
"effectiveness",
post-vaccination
"side
effects",
"community
protection"
"family
protection",
"risk-benefit
ratio",
necessity",
"trust,
"variants
control".
Disparities
uptake
observed
globally,
rates
found
Europe,
regions.
Multiple
including
safety,
efficacy,
side
effects
hesitancy.
Язык: Английский
Sociodemographic and health-related predictors of COVID-19 booster uptake among fully vaccinated adults
Vaccine,
Год журнала:
2025,
Номер
54, С. 127048 - 127048
Опубликована: Март 30, 2025
Язык: Английский
Trust in information sources during the COVID-19 pandemic and its association with vaccine trust among a sample of Hispanic adults
Journal of the American Pharmacists Association,
Год журнала:
2024,
Номер
64(6), С. 102184 - 102184
Опубликована: Июль 10, 2024
Язык: Английский
The Puerto Rico community engagement alliance (PR-CEAL) against COVID-19 disparities: outreach and research engagement efforts in disproportionately affected communities
Frontiers in Public Health,
Год журнала:
2024,
Номер
12
Опубликована: Июль 18, 2024
In
September
2020,
the
National
Institutes
of
Health
acted
in
response
to
COVID-19
pandemic,
recognizing
critical
need
combat
misinformation,
particularly
communities
disproportionately
affected
by
crisis.
The
Community
Engagement
Alliance
(CEAL)
emerged
as
an
initiative
dedicated
fostering
reliable,
science-based
information,
diversity,
and
inclusion;
aiming
implement
effective
strategies
mitigate
spread
nationwide.
One
teams
participating
this
is
Puerto
Rico-CEAL
(PR-CEAL).
Our
whose
goal
was
raise
awareness
about
coronavirus
disease
advance
research,
mainly
focusing
on
vulnerable
underserved
populations.
This
concept
paper
seeks
outline
PR-CEAL’s
infrastructure
during
its
initial
two
cycles,
providing
insights
into
research
community
engagement
activities
designed
enhance
prevention,
counter
foster
uptake
vaccines.
Ultimately,
our
objective
reflect
strengths
challenges
encountered
thus
far
we
endeavor
sustain
robust
infrastructure,
addressing
ongoing
public
health
issues
with
a
forward-looking
approach.
Язык: Английский